Skip to content

Saline Ayvazyan

NPI 1689145807ActiveIndividual· Internal Medicine· Glendale, CA

Internal Medicine in Glendale, California, licensed in CA, with an NPI issued in December 2018. Part D covered 44 prescriptions written in 2024, 89% of them generic. Lilly USA, LLC was the largest of 3 companies reporting payments in 2025, $262.85 in all, mostly food and beverage.

Overview

NPI1689145807
StatusActive
Entity typeIndividual
Sole proprietorYes
NPI issuedDec 16, 2018
Last updated in NPPESDec 1, 2021
Certified by providerDec 1, 2021

Specialties and licenses

TaxonomyCodeLicenseState
Internal Medicine Primary207R00000X95010615CA

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Nurse Practitioner (CA)

Part D prescriptions in 2024

Prescriptions (claims)44 · 45 30-day fills
Patients39
Total drug cost$774.58
Generic share89% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$262.85 · 3 payments from 3 companies
  • 2024$143.90 · 2 payments from 2 companies

Top paying companies in 2025

CompanyAmountPayments
Lilly USA, LLC$119.921
Astrazeneca Pharmaceuticals LP$118.081
Lundbeck LLC$24.851

What the 2025 payments were for

  • Food and Beverage$262.85 · 3 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other internal medicine physicians in Glendale

All 169 internal medicine physicians in Glendale · All internal medicine physicians in California